Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)
13.89
+0.80
(+6.11%)
Streaming Delayed Price
Updated: 12:51 PM EDT, Apr 17, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 763,040 |
| Open | 13.47 |
| Bid (Size) | 13.89 (400) |
| Ask (Size) | 13.90 (400) |
| Prev. Close | 13.09 |
| Today's Range | 13.34 - 13.91 |
| 52wk Range | 7.010 - 15.42 |
| Shares Outstanding | 1,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
| YTD |
+9.7%
|
+9.7%
|
| 1 Month |
+11.7%
|
+11.7%
|
| 3 Month |
+5.3%
|
+5.3%
|
| 6 Month |
+40.7%
|
+40.7%
|
| 1 Year |
+93.5%
|
+93.5%
|
More News
Read More
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
April 09, 2026
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks We Steer Clear Of
April 08, 2026
Via StockStory
Amneal to Report First Quarter 2026 Results on May 1, 2026
April 07, 2026
Via GlobeNewswire
3 Small-Cap Stocks Walking a Fine Line
March 30, 2026
Via StockStory
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
March 10, 2026
Via StockStory
Topics
Stocks
3 Value Stocks We’re Skeptical Of
March 05, 2026
Via StockStory
Amneal to Participate in Upcoming Investor Conference
March 05, 2026
Via GlobeNewswire
Why Amneal (AMRX) Stock Is Trading Lower Today
February 27, 2026
Via StockStory
Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Via The Motley Fool
Topics
Earnings
Amneal (NASDAQ:AMRX) Beats Q4 CY2025 Sales Expectations
February 27, 2026
Via StockStory
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
February 27, 2026
Via GlobeNewswire
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
February 25, 2026
Via StockStory
Topics
Artificial Intelligence
Via MarketMinute
3 Russell 2000 Stocks We Find Risky
February 12, 2026
Via StockStory
3 Small-Cap Stocks That Fall Short
February 04, 2026
Via StockStory
3 Cash-Producing Stocks That Concern Us
February 01, 2026
Via StockStory
3 Healthcare Stocks We Steer Clear Of
January 29, 2026
Via StockStory
Topics
Stocks
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 28, 2026
Via GlobeNewswire
2 Reasons to Sell AMRX and 1 Stock to Buy Instead
January 25, 2026
Via StockStory
Frequently Asked Questions
Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.89
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 04/17/26 12:51 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 13.89K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 14K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>